Skip to main content

FSA in broker banning action first

The Financial Services Authority has today banned David Holland, sole director of Flett Sinclair Insurance Brokers Limited and Petsure Limited, for misusing customers' assets. This is the first time the FSA has taken action against a pet insurance intermediary.

From September 2005 to May 2007, Mr Holland marketed and sold pet insurance policies to customers through Petsure Limited, an agency of FSIB. During that period he: placed premiums amounting to at

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Show password
Hide password

Q&A: Andy Wright, Resnova

Andy Wright, co-founder of a new consultancy firm, Resnova, speaks to Insurance Post about his time at Tesla and Zego, why he wanted to set up a consultancy firm, and why he thinks the next wave of insurtech funding could be coming from China and the Middle East.

FCA ends premium finance probe looking like a tired parent

Editor’s View: Two years after the Financial Conduct Authority kicked off about premium finance, Emma Ann Hughes feels the regulator’s market study final report felt more like finger-wagging from a worn-out parent than meaningful action from a watchdog with a powerful bite.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here